Glaucoma Pharmacology Flashcards

1
Q

Glaucoma

A

A group of conditions that have in common damage to the optic nerve (optic neuropathy)

There are numerous variables that influence glaucoma development, but increased intraocular pressure is the only treatable factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glaucoma Visual Impact

A

Extreme: central island of vision
You slowly lose peripheral vision. It’s a gradual onset. A lot of people don’t notice it. large amounts of people walk around with it undiagnosed
Untreated glaucoma: lights out blind. the central island is snuffed out and they go into complete darkness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Open Angle Glaucoma

A

80% of cases in the US

If you look at angle of the eye, it anatomically looks open cause the pressure is high

Genetic component as well as anatomic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Closed Angle Glaucoma

A

60-80% of cases in Asia

Angle looks crowded, looks like drain of eye is compromised

Genetic component as well as anatomic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Glaucoma Epidemiology

A

Not only a chronic disease but a common one

70 mil world wide
3 mil in the US
2.75 of the 3 mil have open angle glaucoma

So many people are undiagnosed that its hard to know if this is an underestimation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most common causes of blindness

A

Reversible blindness: cataracts

Irreversible blindness: glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Demographics

A

Due to it’s chronicity, prevalence increases with age

By the time people get in their 80s, very large number of people get it

Academy of Ophthalmology recommends annual eye exams after the age of 40

African Americans are more likely to have a diagnosis and it tends to be more aggressive. They go blind quicker.

Even when you look at non-Hispanic whites (still about 8% of population in their age range, so it’s still common)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Risk Factors

A

African American Heritage
Fam Hx (cluster of genetic markers rather than a clearly delineated predisposition)
Older than 40
Elevated intraocular pressure
Use of topical or systemic steroids: overlooked by many. When you put people on steroids, about 10% of those people have an abrupt increase in intraocular pressure. this may tip them over the edge if they already have risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Societal Impact of Glaucoma

A

Individual impact: 120,000 blind from glaucoma-in spite of treatment, 10% lose eyesight

Societal: 10 million doctor visits per year. cost of glaucoma to the US gov is 1.5 billion per year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Glaucoma Pathogenesis

A
  • Glaucoma is a progressive optic neuropathy
  • degeneration of the retinal ganglion cells leading to a characteristic optic nerve head appearance known as “cupping”
  • Progression is related to intraocular pressure (IOP)
  • damage occurs at the lamina cribrosa. compressive axonal injury and decreased axonal transport
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Open Angle Glaucoma (pathogenesis)

A
  • ciliary processes: create fluid inside the eye. Aqueous humor is created here, goes through posterior chamber, goes through the pupil and goes through the Canal of Schlemm. Ordinarily this is what happens
  • —in open angle: it’s exactly what it looks like (normal anatomy at the anterior chamber BUT there’s a decreased efficiency of the trabecular mesh work. So it’s produced normally but there’s a relative inefficiency that happens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Narrow Angle Glaucoma (pathogenesis)

A

There’s crowding of the angle

There’s an anatomical obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aqueous Humor Dynamics

A
  • the aqueous is nutrition to the avascular cornea and lens
  • ultrafiltration and secretion: targets for drugs
  • Tight junctions at the nonpigmented epithelium create a blood-eye barrier
  • aqueous is produced at the rate of 2-3 microliters/min

can’t have things in the eye that are vascularized: need to be CLEAR. Eye requires a lot of nutrition to be able to maintain a clear image

-it’s a dynamic balance: constant production and resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aqueous Humor Dynamics-Production

A

In the ciliary process core

There’s a pump mediated by CARBONIC ANHYDRASE. It pumps aqueous into the posterior chamber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Making the Diagnosis

A
  • measuring pressure
  • evaluation of the angle (where the action is)
  • visualization of the optic nerve
  • measurement of the visual field
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intraocular Pressure

A

Normal pressure is 10-21mm Hg (can be relative depending on the individual)

  • diurnal fluctuation (if you suspect someone has high pressure, might keep that in the office all day and measure every few hours)
  • multiple methods for measuring pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Applanation Tonometry

A

Intraocular pressure=contact force/Area of contact

  • gauge to increase pressure that’s exerted
  • can read a gauge, through the ocular that tells us we’ve exerted enough pressure to flatten the cornea and that’s what we read
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Gonioscopy

A

Visualization of Angle structures

  • the way we can see into angle is by using a handheld lens that sits right at surface of eye with a mirror at a specific angle
  • can see into the anterior chamber
  • we can see all the way around for 360 degrees and can evaluate if the anterior chamber is open or not (if can’t see all structures, the angle is closed and we grade how wide or open the angle is on the exam)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Ultrasound biomicroscopy

A

Visualizing the anterior chamber

-becoming the standard of care slowly but surely

20
Q

Visualization of the Optic Nerve

A

-direct ophthalmoscopy

21
Q

Optic Nerve Appearance

A

-Optic nerve normally has a very small cup

When it’s pathologic: takes a bean pot type of appearance and can see elements of lamina cribosa in here. Losing retinal ganglion cells

22
Q

Measuring Visual Field Defects

A
  • you normally have a blind spot (corresponding to location of optic nerve)
  • moderate glaucoma: losing some of the retinal ganglion fibers (translates to losing a bit of their visual field on examination)
  • Severe glaucoma: beginning to develop the central island visual field we talked about
23
Q

Pharmacological Management

A

Elegant correlation with the anterior chamber physiology

24
Q

Treatment of Glaucoma

A
  • goal: decrease IOP to delay retinal ganglion cell death
  • normal IOP is 10-21, but 20-50% of patients have an IOP of less than 22
  • target is to decrease IOP by 20-50% of baseline (no absolute number)
  • topical pharmacologic agents are the first line approach (although we do surgery for it, the first line of offense is to use a topical agent designed to decrease pressure by a specific amount)
25
Q

Approaches to categorizing glaucoma agents

A
  • Autonomic NS vs. Non-ANS
  • Increased outflow or decreased production
  • efficacy:impact on IOP (which of the drops is most likely in a single agent going to decrease IOP by 30%)
  • the importance of categories is to make sure if we’re using more than one drop, that we have an appropriate combination
26
Q

B-Adrenergic Antagonists

Decreased production

A
Timolol
Carteolol
Levobunolol
Betaxolol
Metipranolol
27
Q

Choinergic Agonists (Miotics)

Increased outflow

A

Pilocarpine

Carbachol

28
Q

Adrenergic Agonists (alpha 2)

Initial decreased production followed by increased outflow

A

Apraclonidine (lopidine)

Brimonidine (alphagan P)

29
Q

Carbonic Anhydrase Inhibitors

Decreased production

A

Acetazolamide (diamox)
Methazolamide
Dorzolamide
Brinzolamide

30
Q

Prostaglandins

Increased outflow

A

Bimatoprost
Latanaprost
Travoprost

-usually used for newbies

31
Q

Hyperosmotics

A

Mannitol
Glycerin
Urea

32
Q

Decreased Production of Aqueous Humor

Drugs

A

Beta blockers

33
Q

Uveoscleral Outflow

Drugs that act here

A

Hyperosmotics (people can actually lose aqueous associated with the urea and the sclera)

34
Q

Trabecular Outflow

Drugs that act here

A

Miotic agents

35
Q

Drugs that Decrease Production

A
  • Beta-adrenergic antagonists

- carbonic anhydrase inhibitors

36
Q

Increased Outflow

A
  • cholinergic agents
  • prostaglandins
  • alpha Agonists
37
Q

Autonomic Nervous System

A

Parasympathetic:
-includes both direct binding to cholinergic receptors and indirect inactivation of acetylcholinesterase increases aqueous outflow (increases outflow by constricting the pupil, it pulls the iris root from the trabecular meshwork and opens up the drain)

Sympathetic:

 - beta adrenergic receptors (beta2) increase aqueous production 
 - alpha adrenergic receptors (alpha2) initial decrease in aqueous production then increase aqueous Outflow
38
Q

Cholinergic Agents (agonists) (green cap)

A

Aqueous dynamics:
-increases aqueous outflow through the trabecular meshwork by longitudinal ciliary muscle contraction

  • the oldest category (over 100 years)
  • used infrequently today
  • directly acting Agonists: pilocarpine
  • indirect: echothiophate
    - binds AChE. Succinylcholine choline/Gen Anesthetic contraindication
39
Q

Cholinergic Agonist Mechanism

A

-stimulates cholinergic receptors (muscarinic)

Systemic side effects: lacrimation, salivation, perspiration, bronchial spasm, urinary urgency, nausea, vomiting, and diarrhea

Local side effects: diminished vision (myopia), headache, cataract, miotic cysts, and rarely retinal detachment

Efficacy: QID decreases IOP by 20%

40
Q

Beta Blockers (yellow cap)

A

-causes pupil to dilate

Aqueous dynamics: reductions in aqueous humor production
Mechanism: interrupts binding to beta receptors
Efficacy: QD/BID. Decreases IOP by 19-29% long term drift back to baseline IOP

41
Q

Beta Blockers (side effects)

A

Systemic: fatigue, psychosis, bradycardia, syncope, nausea, impotence, altered response to hypoglycemia, asthma, heart failure, tinnitus, depression, anxiety, hallucinations, abnormal taste sensation

Local (minimal): burning, superficial keratitis, dry eye

42
Q

Alpha Agonists (purple top)

A

Mechanism: decreased aqueous production, and increase uveoscleral outflow

Local side effects: allergic reaction, mydriasis, lid retraction, conjunctival blanching

Systemic side effects: fatigue, drowsiness, decreased resting HR and SBP

Efficacy: BID/TID decreases IOP by 20-40%q

43
Q

Carbonic Anhydrase inhibitors (oral and topical)—orange cap

A

Acetazxolamide (oral)
Methaxolamide (oral)
Dorzolamide (ophthalmic suspension)
Brinzolamide (ophthalmic solution)

44
Q

Carbonic Anhydrase Inhibitors (properties)

A

Aqueous dynamics: aqueous suppression

Mechanism: inhibits CA enzyme at non-pigmented epithelium

Systemic side effects w/ oral use: parasthesia, anorexa, GI upset, headache, altered taste and smell, metabolic acidosis, renal stone, bone marrow suppression, “aplastic anemia”

Contraindication: sulpha allergy, pregnancy

Efficacy; BID/TID 16-23% decreases in IOP

45
Q

Prostaglandin Analogs (main one now)—–blue cap

A

Aqueous dynamics: increased uveoscleral aqueous Outflow

Mechanism: prostaglandin analogue

Minimal systemic side effects

Local side effects: darkening of the a=iris, lengthening and thickening of eyelashes, intraocular inflammation, macular edema

Efficacy: most commonly used 1st agent. QD 20-40% IOP decrease